Feasibility and success of a single-donor red cell program for pediatric elective surgery patients

R G Strauss1, M R Wieland, M J Randels

  • 1Department of Pathology, University of Iowa College of Medicine, Iowa City.

Transfusion
|October 1, 1992
PubMed

Insights

Limiting exposure to multiple blood donors is beneficial. A single-donor program successfully provided all red blood cells for most pediatric elective surgery patients ineligible for autologous donation.

Area of Science:

  • Transfusion Medicine
  • Pediatric Surgery

Background:

  • Allogeneic blood transfusions carry small risks, necessitating strategies to minimize donor exposure.
  • Autologous blood donation is not feasible for all patients, particularly children undergoing elective surgery.

Purpose of the Study:

  • To evaluate the feasibility and effectiveness of a single-donor program for red blood cell (RBC) provision in pediatric elective surgery patients.
  • To reduce exposure to multiple donors for patients ineligible for autologous blood donation.

Main Methods:

  • A program was implemented where one donor provided all RBC units for each patient.
  • Seventy-three pediatric patients and 115 potential donors (primarily parents) were enrolled.
  • Donor eligibility and completion of RBC donations were tracked, along with patient transfusion outcomes.

Main Results:

  • Ninety donors (78%) were eligible, with 21 deemed ineligible due to RBC incompatibility.
  • Fifty-eight donors (79%) completed all ordered RBC donations.
  • Forty-six patients (63%) received transfusions, with 38 (83%) receiving exclusively single-donor RBCs.

Conclusions:

  • A single-donor blood program effectively met the RBC needs for the majority of pediatric elective surgery patients.
  • This approach significantly limits donor exposure for patients who cannot utilize autologous blood donation.
  • Single-donor programs are a viable consideration for elective surgery patients at risk of multiple donor exposure.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...